Novel SAMD9 Variant Causing MIRAGE Syndrome Treated with Subcutaneous Immunoglobulin

J Clin Immunol. 2024 Sep 30;45(1):19. doi: 10.1007/s10875-024-01808-4.
No abstract available

Keywords: SAMD9; Autoinflammation; Immunodeficiency; MIRAGE.

Publication types

  • Letter
  • Case Reports

MeSH terms

  • Female
  • Humans
  • Immunoglobulins / genetics
  • Immunoglobulins / therapeutic use
  • Intracellular Signaling Peptides and Proteins* / genetics
  • Male
  • Mutation / genetics
  • Treatment Outcome

Substances

  • SAMD9 protein, human
  • Intracellular Signaling Peptides and Proteins
  • Immunoglobulins